Cancer Genetics (CGIX) Tops Q4 EPS by 7c, Revenue Beats
Go back to Cancer Genetics (CGIX) Tops Q4 EPS by 7c, Revenue Beats| CANCER GENETICS (NASDAQ: CGIX) | Delayed: 4.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.61 | 52 Week High | $3.82 | |||
| Open | $1.90 | 52 Week Low | $1.10 | |||
| Day High | $4.61 | P/E | N/A | |||
| Day Low | $4.61 | EPS | $0.00 | |||
| Volume | 50 | |||||
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 74.13 +0.68 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.45 | 52 Week High | $13.18 | |||
| Open | $72.70 | 52 Week Low | $6.00 | |||
| Day High | $74.26 | P/E | N/A | |||
| Day Low | $72.12 | EPS | $-1.24 | |||
| Volume | 1,756,949 | |||||
